密爾克衞(603713.SH):控股子公司取得建築工程施工許可證
格隆匯4月12日丨密爾克衞(603713.SH)公佈,2022年4月11日,公司控股子公司密爾克衞天津取得了天津市西青區行政審批局下發的《中華人民共和國建築工程施工許可證》,工程名稱為“密爾克衞(天津)供應鏈科技有限公司新建危險化學品倉庫及附屬用房項目”。
在該工程投產後,將針對芯片半導體行業,優先滿足中芯國際集成電路製造(天津)有限公司及其配套商的倉儲需求;同時也為轄區內其他有危險化學品需求的企業提供安全、高效的倉儲服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.